Listing & Compliance Notices

Aptose Biosciences Inc. received a nasdaq deficiency notice notice regarding other (rules 5635(d)).

“February 29, 2024, Aptose Biosciences Inc. (the “Company”) received a deficiency letter (the “Deficiency Letter”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company’s recent issuance of securities to Hanmi Pharmaceutical Co., Ltd. (the “Hanmi Transaction”) violated 5635(d) because the Company did not obtain shareholder approval prior to such issuance. Nasdaq stated that completion of the Hanmi Transaction involved the issuance of greater than 20% of the issued and outstanding common shares of the Company at a disco”

Trio Petroleum Corp received a nyse_american noncompliance notice notice regarding minimum bid price (rules 1003(f)(v)).

“February 26, 2024, Trio Petroleum Corp., a Delaware corporation (the “ Company ”) received written notice (the “ Notice ”) from the NYSE American LLC (“ NYSE American ”) indicating that the Company is not in compliance with the continued listing standard set forth in Section 1003(f)(v) of the NYSE American Company Guide (“ Section 1003(f)(v) ”) because the shares of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”) have been selling for a substantial period of time at a low price per share. The Notice has no immediate effect on the listing or trading of the Company”

Aquaron Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules 5550(a)(3)).

“February 28, 2024, Aquaron Acquisition Corp. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it currently does not satisfy Listing Rule 5550(a)(3), which requires the Company to have at least 300 public holders (as defined in Listing Rule 5005(a)(36)) for continued listing on the Nasdaq Capital Market (the “Minimum Public Holders Rule”). The Notice is a notification of deficiency, not of imminent delisting, and has no immediate effect on the listing or trading of t”

ZyVersa Therapeutics, Inc. received a nasdaq compliance regained notice regarding market value (rules 5450(b)(1)(C)).

“February 29, 2024, the Company received approval from Nasdaq to transfer the listing of the Company’s Common Stock from the Nasdaq Global Market to the Nasdaq Capital Market (the “Approval”). The Company’s Common Stock will be transferred to the Nasdaq Capital Market effective as of the open of business on March 1, 2024, and will continue to trade under the symbol “ZVSA.” The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market, and listed companies must meet certain financial requirements and comply with Nasdaq’s corporate governance requirements. As of”

Nova Vision Acquisition Corp received a nasdaq delisting notice notice regarding shareholders (rules 5550(a)(3)).

“February 27, 2024, Nova Vision Acquisition Corp. (the “Company”) received a notice from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”) by 4:00 p.m. Eastern Time on March 5, 2024, the Company’s securities (units, ordinary shares, warrants, and rights) would be subject to suspension and delisting from The Nasdaq Capital Market at the opening of business on March 7, 2024, due to the Company’s non-compliance with Nasdaq Listing Rule 5550(a)(3)”

Barnes & Noble Education, Inc. received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01C).

“February 27, 2024, Barnes & Noble Education, Inc. (the “ Company ”) was notified by the New York Stock Exchange (the “ NYSE ”) that the average closing price of the Company’s shares of common stock, par value $0.01 per share (the “ Common Stock ”), had fallen below $1.00 per share over a period of 30 consecutive trading days, which is the minimum average closing price required to maintain continued listing on the NYSE under Section 802.01C of the NYSE Listed Company Manual. The notice has no immediate impact on the listing of the Common Stock. The Company intends to actively monitor the closin”

Ashford Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii)).

“December 20, 2023, Ashford Inc. (the “Company”) received a letter (the “Letter”) from the NYSE American LLC (the “NYSE American”) stating that the Company was not in compliance with the continued listing standards set forth in Sections 1003(a)(i) and (ii) of the NYSE American Company Guide (the “Company Guide”). Section 1003(a)(i) requires a listed company to have stockholders’ equity of $2 million or more if the listed company has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years. Section 1003(a)(ii) requires a listed company to have sto”

Sunshine Biopharma Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii)).

“February 28, 2024, the Company received a notification letter from Nasdaq advising that Nasdaq’s staff had determined that as of February 27, 2024, the Company’s common stock had a closing bid price of $0.10 or less for ten consecutive trading days and accordingly, the Company was subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”). Accordingly, Nasdaq determined to remove the Company’s securities from listing and registration on The Nasdaq Stock Market, subject to the procedures set forth in the Nasdaq Listing Rule 5800 Series which prov”

TECHPRECISION CORP received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“February 26, 2024, TechPrecision Corporation (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it had not timely filed its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2023 (the “Q3 Form 10-Q”) with the Securities and Exchange Commission (the “SEC”) on or before February 20, 2024, the extended period provided for the filing under Rule 12b-25(b) of the Securities Exchange Act of 1934, as amended.”

Kairous Acquisition Corp. Ltd received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“February 23, 2024, the Company received a written notification from Staff dated February 23, 2024 (the “February Notice”). The February Notice indicated that the Company did not meet the $50,000,000 minimum market value of listed securities required to maintain continued listing as set forth in Nasdaq Marketplace Rule 5450(b)(2)(A) for the 30-business day period ended February 22, 2024. The Company believes that the February Notice was sent by mistake, and on February 23, 2024 the Company’s counsel discussed the issue with the Staff. On February 28, 2024, the Company received another written n”

MiNK Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 26, 2024, the Company received a letter (the “Minimum Bid Price Notice”) from Nasdaq notifying the Company that its Class A common stock, $0.0001 par value per share (the “Common Stock”), failed to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) based upon the closing bid price of the Common Stock for the 30 consecutive trading days prior to the date of the Minimum Bid Price Notice from Nasdaq. The Company has been provided an initial compliance period of 180 calendar d”

Slam Corp. received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

“February 26, 2024, Slam Corp., a Cayman Islands exempted company (“ Slam ”), received a notice from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that, unless Slam timely requested a hearing before the Nasdaq Hearings Panel (the “ Panel ”), trading of Slam’s securities on The Nasdaq Capital Market would be suspended at the opening of business on March 6, 2024, due to Slam’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company complete one or more business combinations within 36 months of the”

Presto Automation Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“February 23, 2024, Presto Automation Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with the requirement to maintain a minimum Market Value of Publicly Held Securities (“MVPHS”) of $15 million, as set forth in Nasdaq Listing Rule 5450(b)(2)(C) (the “MVPHS Requirement”), because the MVPHS of the Company was below $15 million for the 35 consecutive business days prior to the date of the Notice. The Notice is in addition to the previously disclosed letters received on February 6, 2024, notifying the C”

Twelve Seas Investment Co. II received a nasdaq deficiency notice notice regarding other (rules IM-5101-2).

“February 27, 2024, Twelve Seas Investment Company II, a Delaware corporation (the “ Company ”), received a notice (the “ Notice ”) from the staff (the “ Staff ”) of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that the Company has failed to comply with Nasdaq IM-5101-2, which requires that a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Pursuant to the Notice, unless the Company timely requests a hearing before the Nasdaq Hearings Panel”

Netcapital Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“February 29, 2024, the Company received a letter (the “Extension Notice”) from Nasdaq notifying the Company that its request for an extension to regain compliance with the minimum bid price requirement has been granted, and the Company has an additional 180 calendar days, or until August 26, 2024, to regain compliance with the minimum bid price requirement. Nasdaq’s determination was based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of”

VERU INC. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“February 21, 2024, Veru Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the quarter ended December 31, 2023 (the “Form 10-Q”) with the Securities and Exchange Commission, the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The Notice has no immediate effect on the listing or trading of the Company’s common stoc”

60 DEGREES PHARMACEUTICALS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“n stating that for the 31 consecutive business day period between January 11, 2024 through February 27, 2024, the common stock of the Company had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until August 26, 2024 (the “Compliance Period”), to regain compliance with the Bid Price Rule. If the Company does not regain compliance with the Bid”

HWH International Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(3)(C), 5810(c)(3)(D)).

“February 22, 2024, HWH International Inc., (the “Company”), received a letter from the Listing Qualifications Department of Nasdaq indicating that, based on the market value of publicly held shares for the previous 31 consecutive business days, the listing of the Company’s ordinary shares are not in compliance with Nasdaq Listing Rule 5450(b)(3)(C) to maintain a minimum market value of publicly held shares of $15,000,000 (the “MVPHS Rule”). Under Nasdaq Listing Rule 5810(c)(3)(D), the Company has a period of 180 calendar days, or until August 20, 2024, to regain compliance with the MVPHS Rule.”

Revelstone Capital Acquisition Corp. received a nasdaq delisting notice notice regarding market value (rules 5452, 5815(a)(1)(B)(ii)(c)).

“February 22, 2024, Revelstone Capital Acquisition Corp. (“ RCAC ” or the “ Company ”) received a notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”), indicating that it failed to maintain a minimum average market value of publicly held shares of $40,000,000 for over 30 consecutive trading days, as required by Listing Rule 5452 (the “ Rule ”). Accordingly, and pursuant to Listing Rule 5815(a)(1)(B)(ii)(c)2 trading of the Company’s listed securities will be suspended from The Nasdaq Global Market on March 4, 2024 (the “ Suspension ”), and a Form 25-NSE will be filed with the Se”

ARYA Sciences Acquisition Corp IV received a nasdaq deficiency notice notice regarding other (rules IM-5101-2).

“February 26, 2024, ARYA Sciences Acquisition Corp IV (“ARYA”) received a notice from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, unless ARYA timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”) by March 4, 2024, trading of ARYA’s securities on the Nasdaq Capital Market would be suspended at the opening of business on March 6, 2024, due to ARYA’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company complete one or more business combinations within 36 months of the”

Monopar Therapeutics received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“February 27, 2024, the Company received a letter from Nasdaq notifying that the Company had been granted an additional 180-day extension to August 26, 2024 (“Extended Compliance Period”) to regain compliance with the Minimum Bid Price Requirement, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). If at any time during the Extended Compliance Period, the closing bid price of the Company’s common stock is at least $1.00 per share for a minimum of 10 consecutive business days or up to 20 business days in certain circumstances in NASDAQ's discretion, the Staff will provide written confirmation”

CIMG Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“February 22, 2024, NuZee, Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (“Rule 5250(c)(1)) because the Company did not timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2023 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The Notice has no immediate effect on the listing of the Company’s stock on Nasdaq, and it states that the Company is required to submit a plan to regain compliance with Rule 5250(c)(”

Veradigm Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1), 5620(a)).

“February 27, 2024, Veradigm Inc., a Delaware corporation (the “Company”), received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the common stock of the Company from Nasdaq (the “Decision”). The Decision indicates that the Company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) and Nasdaq Listing Rule 5620(a). The Decision indicates that trading in the Company’s common stock will be suspended effective February 29, 2024. The Decision also indicates that the Company may, within 15 calendar days from”

Forward Industries, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).

“February 22, 2024, Forward Industries, Inc. (the “Company”) received notice (the “Equity Deficiency Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company’s stockholders equity as reported in the Company’s Form 10-Q for the period ended December 31, 2023 (the “Form 10-Q”), did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company’s stockholders’ equity be at least $2,500,000 (“Nasdaq Stockholders’ Equity Rule”). As reported in the Company’s Form 10-Q, the stockholders’ equity of the Company was $2,312,852 as of D”

Semnur Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(3)(A)).

“February 22, 2024, Denali Capital Acquisition Corp. (the “ Company ”) received a letter (the “ Letter ”) from the staff at Nasdaq notifying the Company that, for the 30 consecutive business days prior to the date of the Letter, the Company ’ s Minimum Value of Listed Securities (“ MVLS ”) was below the minimum of $50 million required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A). The staff at Nasdaq also noted in the Letter that the Company is not in compliance with Nasdaq Listing Rule 5450(b)(3)(A), which requires listed companies to have tota”

Vintage Wine Estates, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“February 21, 2024, Vintage Wine Estates, Inc. (“VWE” or the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the Company has not filed its Quarterly Report on Form 10-Q for the period ended December 31, 2023 (the “Form 10-Q”) within the prescribed time period, the Company is not in compliance with the timely filing requirement for continued listing under Nasdaq Listing Rule 5250(c)(1). The Nasdaq notification letter has no immediate effect on the listing or trading of the Company’s common stock on Nasdaq.”

Quadro Acquisition One Corp. received a nasdaq deficiency notice notice regarding other (rules IM-5101-2).

“February 20, 2024, Quadro Acquisition One Corp. (the “ Company ”) received a notice from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that, unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “ Panel ”), trading of the Company’s securities on Nasdaq will be suspended at the opening of business on February 29, 2024, due to the Company’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company complete one or more business combinations within 36 months of the effecti”

View, Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(1)(C)).

“February 23, 2024, View, Inc. (the “Company” or “View”) received a letter (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based on the Company’s market value of publicly held shares for the last 30 consecutive business days, the Company no longer meets the requirement to maintain a minimum market value of publicly held shares of $5,000,000, as set forth in Nasdaq Listing Rule 5450(b)(1)(C) (the “Listing Rule”). The Notice provides View with a grace period of 180 calendar days, or until August 21, 2024, to regain compliance with the Listing Rule. If at any time durin”

CNS Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“February 27, 2024, CNS Pharmaceuticals, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that for the last 30 consecutive business days the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). The notification received has no immediate effect on the Company’s Nasdaq listing. In accordance with Nasdaq Listing Rule 58”

SenesTech, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“February 26, 2024, we received notice from Nasdaq indicating that, while we have not regained compliance with the Rule, the Staff has determined that we are eligible for an additional 180 calendar day period, or until August 19, 2024, to regain compliance. The Staff’s determination was based on (i) our meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and (ii) our providing written notice to Nasdaq of our intent to cure the de”

RiskOn International, Inc. received a nasdaq deficiency notice notice regarding other (rules 5110(a), 5635(b)).

“February 21, 2024, RiskOn International, Inc., a Nevada corporation (the “ Company ”) received a letter (the “ Letter ”) from the Listing Qualifications staff (the “ Staff ”) of the Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that the Staff has determined that the Company has violated Nasdaq Listing Rule 5110(a) (the “ Business Combination Rule ”) and Listing Rule 5635(b) (the “ Shareholder Approval Rule ”) as a result of the acquisition of BitNile.com, Inc. (“ BNC ”), which closed on March 6, 2023 (the “ Business Combination ”). According to the Letter, the alleged violations o”

Veradigm Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“February 27, 2024, the Company announced that, because the Company does not expect to have filed its Annual Report on Form 10-K for the year ended December 31, 2022 (the “Form 10-K”) or its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023 (the “Q1 Form 10-Q”), June 30, 2023 (the “Q2 Form 10-Q”) and September 30, 2023 (together with the Q1 Form 10-Q and the Q2 Form 10-Q, the “Form 10-Qs”) on or before the deadline that The Nasdaq Hearings Panel (the “Panel”) had given the Company to regain compliance with Nasdaq Listing Rule 5250(c)(1), the Company anticipates that it will r”

Cingulate Inc. received a nasdaq noncompliance notice notice regarding board independence (rules 5605).

“December 26, 2023, the Company received an additional letter from the Staff indicating that, based upon the resignation of three members of the Company’s board of directors on December 12, 2023 and December 13, 2023, the Company no longer complied with the independent director, audit committee, compensation committee and independent director oversight of director nominations requirements as set forth in Nasdaq Listing Rule 5605. Pursuant to the Exception, the Company is required to provide the Panel with prompt notification of any significant events that occur including any event that may call”

Cingulate Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“February 22, 2024, the Nasdaq Hearings Panel (the “Panel”) notified Cingulate Inc. (the “Company”) that (i) as a result of the appointment of three independent board members on February 12, 2024, it had regained compliance with the board composition requirements of Nasdaq set forth in Nasdaq Listing Rule 5605 and (ii) it has granted the Company’s request for an exception to evidence continued compliance with the minimum stockholders’ equity requirement of $2.5 million under the Nasdaq Listing Rule 5550(b)(1) (the “Minimum Stockholders’ Equity Rule”) for continued listing through May 13, 2024 (”

CORNER GROWTH ACQUISITION CORP. 2 received a nasdaq deficiency notice notice regarding shareholders (rules 5550(a)(3)).

“February 22, 2024, Corner Growth Acquisition Corp. 2 (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company no longer meets the minimum 300 public holders requirement for The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(3) (the “Minimum Public Holders Requirement”). In accordance with Nasdaq rules, the Company has 45 calendar days, or until April 8, 2024, to submit a plan to regain compliance with the Minimum Public Holders Requirement. The Notice is only a not”

Moringa Acquisition Corp received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

“February 20, 2024, Moringa Acquisition Corp, a Cayman Islands exempted company (the “ Company ”) received a notice from the staff of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) indicating that unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “ Panel ”), trading of the Company’s securities on The Nasdaq Capital Market would be suspended at the opening of business on February 29, 2024, due to the Company’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company complete one or more bus”

Greenlane Holdings, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1)).

“February 21, 2024, Nasdaq notified the Company in writing (the “Extension Letter”) that while the Company had not regained compliance with the Minimum Bid Price Requirement, it was eligible for an additional 180-day compliance period, or until August 19, 2024, to regain compliance with the Minimum Bid Price Requirement. Nasdaq’s determination was based on the Company having met the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement”

ShiftPixy, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3)).

“February 26, 2024, ShiftPixy, Inc. (the “Company”) received a letter (the “Nasdaq Letter”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), which notifies the Company that it does not presently comply with Nasdaq’s Listing Rule 5550(b)(2), which requires that the Company maintain a Market Value of Listed Securities (“MVLS”) of $35 million, and that the Company does not otherwise satisfy the requirements of Listing Rules 5550(b)(1) or 5550(b)(3). The Staff calculates MVLS based upon the most recent Total Shares Outstanding (TSO), m”

CorEnergy Infrastructure Trust, Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).

“December 1, 2023, the Company received a written notice from the staff of NYSE Regulation notifying the Company that NYSE Regulation had determined to commence proceedings to delist the Company's common stock the Preferred Stock from the New York Stock Exchange (“NYSE”). NYSE Regulation reached this decision pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average common stock global market capitalization over a consecutive 30 trading day period of at least $15.0”

REPUBLIC AIRWAYS HOLDINGS INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“February 21, 2024, Mesa Air Group, Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the period ended December 31, 2023 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The filing delay is not the result of a forthcoming restatement of”

Adamas One Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“n Form 10-Q for the quarterly period December 31, 2023 (the “ Form 10-Q ”), and because, as previously disclosed, the Company remains delinquent in filing its Annual Report on Form 10-K for the period ended September 30, 2023 (the “ Form 10-K ”), the Company does not comply with Nasdaq Listing Rule 5250(c)(1) for continued listing. As a result of this delinquency of not timely filing the Form 10-Q and Form 10-K, the Company has until March 19, 2024, to submit a plan to regain compliance (the “ Compliance Plan Due Date ”) and if Nasdaq accepts such plan, Nasdaq may grant an exception of up to 1”

Spree Acquisition Corp. 1 Ltd received a nyse deficiency notice notice regarding market value (rules 802.01B).

“February 22, 2024, Spree Acquisition Corp. 1 Limited, a Cayman Islands exempted company (“ Spree ” or the “ Company ”) received notice (the “ Notice ”) from the New York Stock Exchange (the “ NYSE ”) that the Company is not in compliance with the continued listing standard set forth in Section 802.01B of the NYSE Listed Company Manual (the “ Listing Rule ”). The Listing Rule requires a listed acquisition company to maintain an average aggregate global market capitalization attributable to its publicly held shares (a “ public float ”) over a consecutive 30 trading day period of at least $40,000”

Lucy Scientific Discovery, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“$2.5 million (the “ Minimum Stockholders’ Equity Requirement ”). As reported in its Form 10-Q, the Company’s stockholders’ equity as of December 31, 2023, was approximately $81,158. In addition, the Company did not meet the alternatives of market value of listed securities or net income from continuing operations as of the date of the Letter. In accordance”

Catcha Investment Corp received a nyse_american delisting notice notice regarding other.

“February 20, 2024, Catcha received a letter from the NYSE American LLC (“ NYSE American ” or the “ Exchange ”) stating that the staff of NYSE Regulation has determined to commence proceedings to delist Catcha’s Class A ordinary shares pursuant to Sections 119(b) and 119(f) of the NYSE American Company Guide because Catcha failed to consummate a business combination within 36 months of the effectiveness of its initial public offering registration statement, or such shorter period that Catcha specified in its registration statement. At this time, Catcha’s Class A ordinary shares have not been su”

NEXTNRG, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)).

“February 21, 2024, the Company received a delist determination letter (the “Delist Letter”) from the Staff advising the Company that the Staff had determined that the Company did not meet the terms of the extension. Specifically, the Company did not complete its proposed transaction to regain compliance with the Equity Rule and evidence compliance on or before February 20, 2024. The Company plans to request an appeal of the Staff’s determination. At a hearing, the Company intends to present its plan for regaining compliance with the Equity Rule, and may request a further extension to complete”

Assertio Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 21, 2024, Assertio Holdings, Inc. (the “Company”) received notification (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company’s common stock is subject to potential delisting from the Nasdaq Capital Market because, for a period of 30 consecutive business days, the bid price of the Company’s common stock has closed below the minimum $1.00 per share requirement for continued listing under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). The Notice does not result in the immediate delisting of the Company’s commo”

Greenbrook TMS Inc. received a nasdaq delisting notice notice regarding other (rules 5550(a)(2), 5550(b)).

“February 22, 2024, Greenbrook TMS Inc. (the “ Company ”) received the final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“ Nasdaq ”) due to the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders’ equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the “ Common Shares ”) will be suspended as of the open of trading on February 26, 2024. After careful consideration, the Company determined th”

Finch Therapeutics Group, Inc. received a nasdaq delisting notice notice regarding other (rules 5101).

“February 16, 2024, Finch Therapeutics Group, Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based on the Staff’s review of the Company and pursuant to Listing Rule 5101, the Staff believes that the Company no longer has an operating business and is a “public shell” and that the continued listing of its securities is no longer warranted. The Company disagrees with Nasdaq’s determination regarding the Company’s status as a “public shell” and, accordingly, has requested an appeal hearing. The hearing request”

RenovoRx, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“February 21, 2024, the Company received a written notice (the “Notice”) from Nasdaq that the Company had, as of the date of the Notice, failed to meet the Minimum Stockholders’ Equity Requirement and that Nasdaq would commence delisting proceedings against the Company unless the Company timely requests a hearing before the Nasdaq Hearing Panel (the “Hearing Panel”). The Company plans to request a hearing, which request will stay any delisting or suspension action by the Nasdaq staff at least pending the issuance of the Hearing’s Panel decision and the expiration of any extension that may be gr”

Arcimoto Inc received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5450(b)(1)(A)).

“February 21, 2024, Arcimoto, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the stockholders’ equity had fallen below $10,000,000 and, as a result, the Company is not in compliance with Nasdaq Listing Rule 5450(b)(1)(A). Nasdaq’s notice has no immediate effect on the listing of the Company’s Common Stock on Nasdaq. The Company has 45 calendar days to submit a plan to regain compliance. If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from February 21, 2024 to e”